[1]
Thimmaiah, N. et al. 2015. Toxicity, Efficacy, and Quality of Life of Addition of IMRT Boost to Whole Brain Radiation Therapy and Concurrent Temozolomide in Patients with Newly Diagnosed Brain Metastases. Reports of Radiotherapy and Oncology. 2, 4 (Dec. 2015), 1–7.